Supplementary Table S2 from A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S2. Inclusion and Exclusion Criteria of Study Participants
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4414864972
Cites:
Cited by:
Related to: